Psoriasis Biologics Face Off in Drug Survival Study  - Top-Institutions - MDSpire

Psoriasis Biologics Face Off in Drug Survival Study 

Danish registry data reveal differences in treatment persistence

  • By

  • Julie Greenbaum

  • January 14, 2026

  • 2 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Copenhagen University Hospital–Herlev and Gentofte
    Copenhagen University Hospital–Herlev and Gentofte

    Copenhagen, Denmark

    Key Differentiators

    • Dermatology
    • Clinical Research

  • #2

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Immunology

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Dermatology
    • Clinical Epidemiology

  • #4

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Clinical Research

  • #5

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH

    Bethesda, MD

    Key Differentiators

    • Dermatology
    • Immunology
    • Clinical Research

Original Source(s)

Psoriasis Biologics Face Off in Drug Survival Study 

  • by Julie Greenbaum

  • January 14, 2026

Related Content

Coordinated Care Strategies for Psoriasis: An Organized Method for Timely Identification and Referral of Comorbid Conditions

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial

Dupilumab Gains Pediatric CSU Approval

Targets type 2 inflammation in a population with limited treatment options